SGP
Income statement / Annual
Last year (2025), SpyGlass Pharma Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, SpyGlass Pharma Inc.'s net income was -$39.87 M.
See SpyGlass Pharma Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
| Period Ended |
12/31/2025 |
| Operating Revenue |
$0.00 |
| Cost of Revenue |
$612.00 K
|
| Gross Profit |
-$612.00 K
|
| Gross Profit Ratio |
0
|
| Research and Development Expenses |
$28.64 M
|
| General & Administrative Expenses |
$12.20 M
|
| Selling & Marketing Expenses |
$0.00
|
| Selling, General & Administrative Expenses |
$12.20 M
|
| Other Expenses |
$0.00
|
| Operating Expenses |
$40.84 M
|
| Cost And Expenses |
$41.45 M
|
| Interest Income |
$3.11 M
|
| Interest Expense |
$0.00
|
| Depreciation & Amortization |
$612.00 K
|
| EBITDA |
-$39.26 M |
| EBITDA Ratio |
0
|
| Operating Income Ratio |
0
|
| Total Other Income/Expenses Net |
$1.58 M
|
| Income Before Tax |
-$39.87 M
|
| Income Before Tax Ratio |
0
|
| Income Tax Expense |
$0.00
|
| Net Income |
-$39.87 M
|
| Net Income Ratio |
0
|
| EPS |
-1.19 |
| EPS Diluted |
-1.19 |
| Weighted Average Shares Out |
$33.43 M
|
| Weighted Average Shares Out Diluted |
$33.43 M
|
| Link |
|
